A Phase III, randomized, controlled, observer-blind study to demonstrate effectiveness, immunogenicity and safety of GSK's meningococcal Group B and combined ABCWY vaccines when administered to healthy adolescents and young adults (Quintet)

Investigators: Andrea Meehan, Beth Arrowsmith, Camille Gibson, Christina Anthony, Fiona McDonald, Heidi Hutton, Jan Jones, Jane Jones, Jennifer Kent, Joanne Ong, Kieran Veale, Lisa Montgomery, Miriam West, Nikki Schultz, Peter Richmond, Ushma Wadia

Project description

The QUINTET Study will evaluate the effectiveness of a potential vaccine called MenABCWY.

The investigational vaccine is designed to help protect against the A, B, C, W and Y strains of the meningococcal disease.

Partners